Clinical Trial

Development and Validation of a Disease Specific PROM to Assess Abdominal Involvement in Patients With CF (CFAbd-Score)

Study acronym: CFAbd-Score
Recruiting
View on ClinicalTrials.gov →
Summary
Development, validation and evaluation of a new multimodal questionnaire to assess and quantify the abdominal involvement in patients with the inherited life shortening multi-organ disease Cystic fibrosis. In the stepwhise development of the patient reported outcome measures (PROM) repeadedly, CF-patients, their families as well as professionals working in different fields of CF-care will be included.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2017-02-13; most recent amendment 2023-03-31.
Trial Details
NCT Number NCT03052283
Lead Sponsor Medizinische Hochschule Brandenburg Theodor Fontane
Collaborators: University of Jena
Conditions Cystic Fibrosis
Enrollment 2,000 participants
Start Date 2017-01-26
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-04-04